Grifols is a global healthcare, biotechnology, and manufacturing company focused on plasma-derived medicines and other solutions for patients with rare diseases and chronic conditions. Its work spans research and development, pharmaceutical production, and worldwide distribution, making Grifols a relevant employer for professionals interested in biotechnology, biopharmaceutical manufacturing, and healthcare innovation.
MSD is a global biopharmaceutical company advancing medicines and vaccines for major health challenges, including cancer, infectious diseases, cardiovascular and metabolic conditions, and prevention-focused care. Known as Merck & Co., Inc. in the United States, Canada, and Puerto Rico, MSD combines scientific research with development and commercial expertise to bring healthcare solutions to people and animals.
Its work spans Human Health, Animal Health, and Research & Development, creating opportunities for professionals across scientific, clinical, commercial, operational, and corporate teams. With activities in regions around the world, MSD’s careers reflect its focus on research, collaboration, inclusion, and responsible progress in global health.
Abbott is a global healthcare company developing technologies and products across diagnostics, medical devices, nutrition, and branded generic medicines. Its portfolio includes FreeStyle Libre glucose monitoring systems and BinaxNOW rapid antigen tests, serving patients and healthcare professionals in areas such as diabetes management, infectious disease, and nutrition. Abbott’s work also focuses on expanding access to care, supporting health equity, and addressing challenges including malnutrition and infectious diseases. For professionals exploring healthcare careers, the company offers opportunities to contribute to medical innovation across a broad range of health-related disciplines.
Johnson & Johnson is a global healthcare company working across pharmaceuticals, medical devices, and consumer health. Its research and product development activities include medicines and therapies for oncology, immunology, neuroscience, and cardiopulmonary conditions, alongside MedTech solutions for cardiovascular care, orthopaedics, surgery, and vision. The company’s wider work also includes health and wellness education, large-scale manufacturing, investor activities, and global social-impact initiatives, creating opportunities across scientific, clinical, engineering, manufacturing, commercial, and corporate functions.
Natera develops cell-free DNA testing and bioinformatics solutions for healthcare. Its diagnostic technologies support non-invasive prenatal screening, cancer detection, and organ transplant monitoring, helping clinicians and patients access genetic insights for more informed care decisions. The company’s work brings together biotechnology, data analysis, and clinical applications across several areas of modern medicine.
Labcorp combines laboratory testing, diagnostics, drug development, and scientific data to support healthcare providers, hospitals, pharmaceutical companies, researchers, and patients. Its global operations serve more than 160 million patients each year, with teams working across a broad laboratory network and more than 100 countries. The company applies advanced technologies, including artificial intelligence and digital tools, to accelerate clinical research, enable precision medicine initiatives such as cell and gene therapies and oncology diagnostics, and help inform medical decisions. Labcorp’s careers span healthcare, pharmaceuticals, biotechnology, laboratory science, technology, and drug development.
Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company developing and commercializing theranostic radiopharmaceuticals for cancer and rare diseases. Its approach combines targeted imaging with radiation-based treatment to support more informed clinical decisions and personalized care.
The company’s pipeline spans prostate and kidney cancer, neuro-oncology, and musculoskeletal cancers. Telix has secured global regulatory approvals for its lead imaging product, Illuccix®, and continues to advance a broad program of clinical trials worldwide. Its team works across healthcare, biotechnology, and related commercial disciplines to bring radiopharmaceutical innovations from development into clinical use.
Avantor is a global life science tools and services company supporting research, development, and production across the life sciences and advanced technology sectors. Its offering spans laboratory consumables, chemicals, equipment, distribution, and laboratory services, helping scientists and organizations move from discovery to delivery in medicine, healthcare, and technology. Avantor serves customers at more than 300,000 locations across 180 countries and operates through more than 200 locations with over 13,500 associates. Its careers site features opportunities across the teams that support this international scientific and operational network.
Philips is a global health technology company developing innovations across personal health, diagnosis and treatment, and connected care. Its work is designed to support better health outcomes for individuals while helping healthcare providers deliver effective, connected care.
BeOne Medicines is a Switzerland-domiciled global oncology company focused on discovering and developing innovative cancer treatments designed to improve affordability and access. Its portfolio covers hematologic cancers and solid tumors, supported by an expanding pipeline of novel therapeutics advanced through in-house capabilities and external collaborations. With more than 11,000 colleagues across six continents, BeOne Medicines is working to broaden access to medicines for patients worldwide.
Amgen is a global biotechnology company that develops and commercializes medicines made from living cells. Its work focuses on serious illnesses, including conditions with limited treatment options, supported by scientific research and clinical trials. The company is associated with advances in cancer treatment and obesity management, while emphasizing ethical research, patient safety, and environmental sustainability.
AstraZeneca is a science-led biopharmaceutical company developing and commercializing prescription medicines for major health challenges. Its work covers oncology, cardiovascular, renal and metabolic conditions, and respiratory disease, combining pharmaceutical research with development and global delivery. With operations across more than 100 countries, AstraZeneca brings together teams focused on advancing treatments and improving outcomes for patients worldwide.
Regeneron is a biotechnology company that discovers, develops, and commercializes medicines for serious and underserved conditions. Its research spans allergy, cardiovascular and metabolic disease, neuroscience, oncology, hematology, ophthalmology, and rare diseases. By combining biological research with advanced technology, Regeneron works on biologics and genetic medicines designed to address complex healthcare needs. The company also highlights health equity, environmental responsibility, scientific education, and ethical corporate practices as part of its broader mission to advance patient care.
Gilead Sciences is a biopharmaceutical company developing and delivering medicines for life-threatening diseases. Its work has a strong focus on virology, including HIV and hepatitis, alongside growing research in oncology and inflammation. The company supports a global portfolio of more than 25 products and 50 clinical programs, while also investing in HIV research and health-equity initiatives. For job seekers, Gilead Sciences offers opportunities to contribute to research, development, and healthcare programs aimed at improving patient outcomes worldwide.
Eli Lilly and Company is a multinational pharmaceutical and healthcare company focused on discovering, developing, manufacturing, and commercializing prescription medicines. Its work spans therapeutic areas including diabetes, oncology, immunology, neuroscience, and pain, combining research and development with clinical trials, regulatory processes, biologic and small-molecule drug production, and global distribution.
Otsuka Pharmaceutical Companies (U.S.) brings together pharmaceutical businesses focused on advancing healthcare through product commercialization and clinical development. Otsuka America Pharmaceutical, Inc. commercializes Otsuka-discovered and in-licensed medicines in North America, while Otsuka Pharmaceutical Development & Commercialization, Inc. leads clinical development and global registration of innovative healthcare products, with particular expertise in neuroscience. Together, these organizations operate across pharmaceuticals, healthcare, and biotechnology with a focus on developing solutions that support better health.
CSL is a global biotechnology and healthcare company developing biotherapeutics and vaccines for people living with serious and rare diseases. Its operations include CSL Behring, which provides treatments for immunodeficiency, hereditary bleeding disorders, and Alpha-1 Antitrypsin Deficiency; CSL Seqirus, a major influenza vaccine provider; and CSL Vifor, focused on iron deficiency and nephrology. Supported by a broad research and development network, CSL works across plasma fractionation, recombinant protein technology, cell and gene therapy, and vaccines. Headquartered in Melbourne, Australia, the company serves patients in more than 100 countries and offers career opportunities across research, manufacturing, healthcare, and biotechnology.
Clinical Outcomes Solutions is a global consultancy focused on clinical outcome assessment (COA) research for pharmaceutical and biotechnology organizations. Its team develops research strategies and practical solutions for capturing reliable data about patients’ experiences, helping clients address the scientific and regulatory complexities of clinical outcomes work. By bringing the patient voice into research design and evidence generation, the company supports informed care decisions and stronger patient outcomes.
ZEISS Group is a global optics and optoelectronics company serving semiconductor manufacturing, industrial quality and research, medical technology, and consumer markets. Founded in 1846 and headquartered in Oberkochen, Germany, the company develops products and technologies including binoculars, microscopy systems, eyeglass lenses, biomedical research solutions, and applications involving artificial intelligence and machine learning. Its approximately 43,000 employees work across nearly 50 countries in research and development, production, sales, and service teams.
Fortrea is a global clinical research organization serving biopharmaceutical and medical technology companies. Its clinical development services span clinical pharmacology, Phase I–IV study management, regulatory strategy, and market access, combining scientific expertise with data-driven approaches. Fortrea supports programs across areas including cell and gene therapy, oncology, cardiovascular disease, and infectious diseases, helping clients make informed development decisions and advance potential treatments toward patients.
